Temozolomide (TMZ) with O6-benzylguanine (BG) plus CPT-11 in the treatment of recurrent malignant glioma: A phase I trial
Publication
, Conference
Desjardins, A; Quinn, J; Reardon, D; Rich, J; Sathornsumetee, S; Vredenburgh, J; Walker, A; Tourt-Uhlig, S; Bigner, D; Friedman, H
Published in: NEURO-ONCOLOGY
July 1, 2005
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
July 1, 2005
Volume
7
Issue
3
Start / End Page
320 / 320
Location
Edinburgh, SCOTLAND
Publisher
DUKE UNIV PRESS
Conference Name
2nd Quadrennial Meeting of the World-Federation-of-Neuro-Oncology/6th Meeting of the European-Association-for-Neur-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Desjardins, A., Quinn, J., Reardon, D., Rich, J., Sathornsumetee, S., Vredenburgh, J., … Friedman, H. (2005). Temozolomide (TMZ) with O6-benzylguanine (BG) plus CPT-11 in the treatment of recurrent malignant glioma: A phase I trial. In NEURO-ONCOLOGY (Vol. 7, pp. 320–320). Edinburgh, SCOTLAND: DUKE UNIV PRESS.
Desjardins, A., J. Quinn, D. Reardon, J. Rich, S. Sathornsumetee, J. Vredenburgh, A. Walker, S. Tourt-Uhlig, D. Bigner, and H. Friedman. “Temozolomide (TMZ) with O6-benzylguanine (BG) plus CPT-11 in the treatment of recurrent malignant glioma: A phase I trial.” In NEURO-ONCOLOGY, 7:320–320. DUKE UNIV PRESS, 2005.
Desjardins A, Quinn J, Reardon D, Rich J, Sathornsumetee S, Vredenburgh J, et al. Temozolomide (TMZ) with O6-benzylguanine (BG) plus CPT-11 in the treatment of recurrent malignant glioma: A phase I trial. In: NEURO-ONCOLOGY. DUKE UNIV PRESS; 2005. p. 320–320.
Desjardins, A., et al. “Temozolomide (TMZ) with O6-benzylguanine (BG) plus CPT-11 in the treatment of recurrent malignant glioma: A phase I trial.” NEURO-ONCOLOGY, vol. 7, no. 3, DUKE UNIV PRESS, 2005, pp. 320–320.
Desjardins A, Quinn J, Reardon D, Rich J, Sathornsumetee S, Vredenburgh J, Walker A, Tourt-Uhlig S, Bigner D, Friedman H. Temozolomide (TMZ) with O6-benzylguanine (BG) plus CPT-11 in the treatment of recurrent malignant glioma: A phase I trial. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2005. p. 320–320.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
July 1, 2005
Volume
7
Issue
3
Start / End Page
320 / 320
Location
Edinburgh, SCOTLAND
Publisher
DUKE UNIV PRESS
Conference Name
2nd Quadrennial Meeting of the World-Federation-of-Neuro-Oncology/6th Meeting of the European-Association-for-Neur-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences